Comparison of the Transcriptomic Signatures in Pediatric and Adult CML

Minyoung Youn1, Stephanie M Smith1, Alex Gia Lee2

  • 1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Cancers
|December 24, 2021
PubMed

Insights

Pediatric chronic myeloid leukemia (CML) shows distinct molecular differences from adult CML, particularly in gene expression and the Rho pathway, impacting disease biology.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genomics

Background:

  • Pediatric and adult chronic myeloid leukemia (CML) exhibit clinical differences, suggesting underlying biological variations.
  • Understanding these differences is crucial for targeted therapies in pediatric CML.

Purpose of the Study:

  • To investigate unique molecular and transcriptomic signatures in pediatric CML.
  • To compare gene expression profiles between pediatric and adult CML CD34+ cells.

Main Methods:

  • High-throughput RNA sequencing of CD34+ cells from pediatric and adult CML patients and healthy controls.
  • Differential gene expression analysis to identify unique molecular characteristics.
  • RT-qPCR validation of key differentially expressed genes.

Main Results:

  • 567 differentially expressed genes found in pediatric CML CD34+ cells compared to healthy controls.
  • 398 differentially expressed genes identified when comparing pediatric and adult CML CD34+ cells, with notable Rho pathway involvement.
  • Specific genes (DLC1, VAV2, ARHGAP27, NCF1, CYBB, S100A8) showed distinct expression patterns in pediatric versus adult CML.

Conclusions:

  • Pediatric CML possesses unique molecular characteristics, including Rho pathway dysregulation.
  • These molecular differences may explain the distinct clinical presentations of pediatric CML.
  • Further research into these unique pathways could lead to novel therapeutic strategies for children with CML.